Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Twelves

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Investigational New Drugs|January 19, 2000
Activity of doxorubicin covalently bound to a novel human serum albumin microcapsuleM Eatock, N Church, R Harris, et al.
British Journal of Cancer|May 31, 2012
Chromosome instability and benefit from adjuvant anthracyclines in breast cancerA F Munro, C Twelves, J S Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The EORTC and drug development. European Organisation for Research and Treatment of CancerD Lacombe, P Fumoleau, H Zwierzina, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Capecitabine named-patient programme for patients with advanced breast cancer. the UK experienceR C F Leonard, C Twelves, J Breddy, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2008
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancerF Caponigro, D Lacombe, C Twelves, et al.
British Journal of Cancer|September 16, 1999
Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumoursA H Thomson, P A Vasey, L S Murray, et al.
The American Review of Respiratory Disease|October 1, 1988
Peripheral T-cell lymphoma presenting with angioedema and diffuse pulmonary infiltratesN K Harrison, C Twelves, B J Addis, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2004
A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acidM Eatock, J Cassidy, J Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinomaC Twelves, M Boyer, M Findlay, et al.
British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|January 19, 2000
Activity of doxorubicin covalently bound to a novel human serum albumin microcapsuleM Eatock, N Church, R Harris, et al.
British Journal of Cancer|May 31, 2012
Chromosome instability and benefit from adjuvant anthracyclines in breast cancerA F Munro, C Twelves, J S Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The EORTC and drug development. European Organisation for Research and Treatment of CancerD Lacombe, P Fumoleau, H Zwierzina, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Capecitabine named-patient programme for patients with advanced breast cancer. the UK experienceR C F Leonard, C Twelves, J Breddy, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2008
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancerF Caponigro, D Lacombe, C Twelves, et al.
British Journal of Cancer|September 16, 1999
Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumoursA H Thomson, P A Vasey, L S Murray, et al.
The American Review of Respiratory Disease|October 1, 1988
Peripheral T-cell lymphoma presenting with angioedema and diffuse pulmonary infiltratesN K Harrison, C Twelves, B J Addis, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2004
A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acidM Eatock, J Cassidy, J Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinomaC Twelves, M Boyer, M Findlay, et al.
British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.
Pageof 8